C Praga
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Platelet Disorders and Treatments
-
- Cancer Treatment and Pharmacology
- Neutropenia and Cancer Infections
Papers in
-
- Platelet Disorders and Treatments 4
- Hemophilia Treatment and Research 2
-
- Blood properties and coagulation 2
- Co-authors
- M. Cortellaro (6 shared papers)Jonas Bergh (1 shared paper)P. Fumoleau (1 shared paper)Lois E. Shepherd (1 shared paper)D. W. O. Rogers (1 shared paper)Patrick Therasse (1 shared paper)Michel Héry (1 shared paper)Bruno Mario Cesana (1 shared paper)
- Journals
- Acta Haematologica (2 papers)Advances in experimental medicine and biology (2 papers)Thrombosis Research (2 papers)Gynecologic and Obstetric Investigation (1 paper)Oncology (1 paper)
- Partner nations
- ItalySwitzerlandAustria
In The Last Decade
C Praga
26 papers receiving 273 citations
Peers
Comparison fields: 5 of 70
- Hematology 91
- Oncology 112
- Cancer Research 50
- Cardiology and Cardiovascular Medicine 50
- Genetics 23
Countries citing papers authored by C Praga
This map shows the geographic impact of C Praga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Praga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Praga more than expected).
Fields of papers citing papers by C Praga
This network shows the impact of papers produced by C Praga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Praga. The network helps show where C Praga may publish in the future.
Co-authors
The 25 scholars most cited alongside C Praga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 136 | |
| 2 | 1980 | 19 | |
| 3 | 1972 | 19 | |
| 4 | 1985 | 17 | |
| 5 | 1984 | 13 | |
| 6 | Inhibition of human platelet aggregation by oral administration of nicergoline. A double-blind study. | 1975 | 11 |
| 7 | 1975 | 10 | |
| 8 | 1972 | 9 | |
| 9 | 1973 | 8 | |
| 10 | 1975 | 8 | |
| 11 | 1980 | 8 | |
| 12 | 1972 | 6 | |
| 13 | 1982 | 6 | |
| 14 | 1978 | 4 | |
| 15 | 1972 | 4 | |
| 16 | 1975 | 3 | |
| 17 | 1972 | 3 | |
| 18 | 1967 | 3 | |
| 19 | 1968 | 2 | |
| 20 | 1974 | 2 |
About C Praga
C Praga is a scholar working on Hematology, Pulmonary and Respiratory Medicine, Surgery, Oncology and Cardiology and Cardiovascular Medicine, having authored 26 papers that have together received 299 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Soft tissue tumor case studies (2 papers), Hemophilia Treatment and Research (2 papers), Parathyroid Disorders and Treatments (2 papers), Neurofibromatosis and Schwannoma Cases (2 papers), Blood properties and coagulation (2 papers) and Pharmacology and Obesity Treatment (2 papers). The work is most often cited by research in Hematology (91 citations), Oncology (112 citations), Cancer Research (50 citations), Cardiology and Cardiovascular Medicine (50 citations) and Genetics (23 citations). C Praga has collaborated with scholars based in Italy, Switzerland and Austria. Frequent co-authors include M. Cortellaro, Jonas Bergh, P. Fumoleau, Lois E. Shepherd, D. W. O. Rogers, Patrick Therasse, Michel Héry, Bruno Mario Cesana, R. Charles Coombes and Rosa Giuliani. Their work appears in journals such as Acta Haematologica, Advances in experimental medicine and biology, Thrombosis Research, Gynecologic and Obstetric Investigation and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.